Patent Trends across Oncolytic Virotherapy-Genetic Alert

Patent Trends across Oncolytic Virotherapy-Genetic Alert

RELEASE DATE
01-Apr-2016
REGION
Global
Research Code: D758-00-0D-00-00
SKU: HC02860-GL-TA_20521

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC02860-GL-TA_20521

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Genetic Alert depicts the current patent landscape and the new life sciences trends across oncolytic virotherapy. Analyst insights on oncolytics viral therapies are also included.

The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: cancer therapeutics, oncolytic viral therapies, clinical trials, reovirus therapy, tumor, ovarian cancer, companion imaging

Table of Contents

Patent Trend-Based Profiles

  • Oncolytic Viruses and Virotherapy a Rapidly Evolving Space in the Future of Cancer Therapeutics
  • Genelux Corporation has the Highest Number of Granted Patents
  • Key Granted Patents from the Top Applicants (2012 to 2016)
  • Key Granted Patents from the Top Applicants (2012-2016)
  • Oncolytic Viral Therapies Entering Late Stage Clinical Trials
  • Reovirus Therapy shows Statistical Significance in Reducing Tumor Burden among Ovarian Cancer Patients
  • Companion Imaging Modality Works Synergistically with Oncolytic Viral Therapy

Strategic Perspectives

  • Strategic Trends

Appendix

  • Industry Interactions
Related Research
This edition of the Genetic Alert depicts the current patent landscape and the new life sciences trends across oncolytic virotherapy. Analyst insights on oncolytics viral therapies are also included. The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: cancer therapeutics, oncolytic viral therapies, clinical trials, reovirus therapy, tumor, ovarian cancer, companion imaging
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D758-00-0D-00-00
Is Prebook No
Ti Codes D758